Annexon, Inc.

BRISBANE, CA How do I update this listing?

Create Email Alert

Annexon is based out of Brisbane. Annexon, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. The firm last filed a Form D notice of exempt offering of securities on 2022-07-22. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

annexon, inc.
1400 SIERRA POINT PARKWAY
BRISBANE CA    94005

Business Phone: (650)-822-5500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2022-07-22 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 130,475,296 130,475,296 0
2020-07-16 D BIOTECHNOLOGY Equity 101,999,983 101,999,983 0
2018-12-19 D BIOTECHNOLOGY Equity 84,999,985 44,999,994 39,999,991
2011-08-22 D OTHER HEALTH CARE Equity 999,999 999,999 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BEN BARRES subscription required
    DIRECTOR
ARNON ROSENTHAL subscription required
    DIRECTOR
STACIE WENINGER subscription required
    DIRECTOR
DOUGLAS LOVE subscription required
    EXECUTIVE OFFICER DIRECTOR
MARK L SMITH subscription required
    EXECUTIVE OFFICER
RICKY SUN subscription required
    DIRECTOR
CAROL GALLAGHER subscription required
    DIRECTOR
CAMPBELL MURRAY subscription required
    DIRECTOR
MUNEER SATTER subscription required
    DIRECTOR
EMMETT CUNNINGHAM subscription required
    DIRECTOR
THOMAS WIGGANS subscription required
    DIRECTOR
WILLIAM YOUNG subscription required
    DIRECTOR
TED YEDNOCK subscription required
    EXECUTIVE OFFICER
SANJAY KESWANI subscription required
    EXECUTIVE OFFICER
JENNIFER LEW subscription required
    EXECUTIVE OFFICER
JUNG E. CHOI subscription required
    DIRECTOR
WILLIAM H. CARSON, M.D. subscription required
    DIRECTOR
BETTINA M. COCKROFT, M.D. subscription required
    DIRECTOR
WILLIAM D. WADDILL subscription required
    DIRECTOR
LARRY C. MATTHEAKIS, PH.D subscription required
    EXECUTIVE OFFICER
MICHAEL OVERDORF subscription required
    EXECUTIVE OFFICER

Elevate your investments